Research ArticleClinical Studies

Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life

HITOSHI ISHIKAWA, HIROYUKI KATOH, TAKUYA KAMINUMA, HIDEMASA KAWAMURA, KAZUTO ITO, HIROSHI MATSUI, JUNKO HIRATO, NOBUAKI SHIMIZU, YUTAKA TAKEZAWA, HIROSHI TSUJI, KAZUHIRO SUZUKI, TATSUYA OHNO, TAKASHI NAKANO and GROUP FOR GENITOURINARY TUMORS AT GUNMA HEAVY ION MEDICAL CENTER
Anticancer Research October 2015, 35 (10) 5559-5566;

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    A representative dose distribution of carbon-ion radiotherapy: axial view (A), sagittal view (B), and coronal view (C). Contours by light-yellow, green, and light-green lines indicate the initial planning target volume, prostate, and proximal seminal vesicles, respectively.

  • Figure 2.
    Figure 2.

    Overall survival and recurrence-free survival curves after carbon-ion radiotherapy for prostate cancer.

  • Figure 3.
    Figure 3.

    Normalized rectal volume receiving 10% (V10) to 100% (V100) of the prescribed dose for all treatment plans. The averages of the rectal V30, V50, V70, and V90 in the present study were 17.2±4.1%, 10.9±2.7%, 7.0±2.0%, and 3.6±1.2%, respectively.

Tables

  • Table I.
  • Table II.
  • Table III.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life
HITOSHI ISHIKAWA, HIROYUKI KATOH, TAKUYA KAMINUMA, HIDEMASA KAWAMURA, KAZUTO ITO, HIROSHI MATSUI, JUNKO HIRATO, NOBUAKI SHIMIZU, YUTAKA TAKEZAWA, HIROSHI TSUJI, KAZUHIRO SUZUKI, TATSUYA OHNO, TAKASHI NAKANO, GROUP FOR GENITOURINARY TUMORS AT GUNMA HEAVY ION MEDICAL CENTER
Anticancer Research Oct 2015, 35 (10) 5559-5566;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords